Status:
UNKNOWN
A New Screening Strategy for 2019 Novel Coronavirus Infection
Lead Sponsor:
Affiliated Hospital to Academy of Military Medical Sciences
Collaborating Sponsors:
Beijing 302 Hospital
Conditions:
Novel Coronavirus Infection Pneumonia
Eligibility:
All Genders
Phase:
NA
Brief Summary
Since Dec 2019, over 70000 novel coronavirus infection pneumonia (NCIP) patients were confirmed. 2019 novel coronavirus (2019 nCoV) is a RNA virus, which spread mainly from person-to-person contact. M...
Detailed Description
This clinical trial is designed to compare the screen accuracy and efficiency of two screening strategies. Considering that the general population is susceptible to 2019 nCoV, a great number of people...
Eligibility Criteria
Inclusion
- Who agree to participate in the study and sign written informed consent
Exclusion
- Confirmed NCIP patients
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2020
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT04281693
Start Date
February 1 2020
End Date
March 1 2020
Last Update
February 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Fifth Medical Center of Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100071